References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
BADIanietal(1995)Intra-VTAinjectionsofthemu-opioidantagonistCTOPenhancelocomotoractivity.BrainRes.690112PMID:7496796
Gulyaetal(1988)CentraleffectsofthepotentandhighlyselectivemuopioidantagonistD-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2(CTOP)inmice.Eur.J.Pharmacol.150355PMID:2901358
Hawkinsetal(1989)[3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2]([3H]CTOP),apotentandhighlyselectivepeptideformuopioidreceptorsinratbrain.J.Pharmacol.Exp.Ther.24873PMID:2563293
Chiengetal(1996)Theμ-opioidreceptorantagonistD-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2(CTOP)[butnotD-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2(CTAP)]producesanoMol.Pharmacol.50650PMID:8794906
Keywords:CTOP,supplier,selective,potent,μ-opioid,mu-opioid,antagonists,MOP,Receptors,OP3,Mu,Opioid,Receptors,Mu,Opioid,Receptors,TocrisBioscience